−0.000AUD
−1.61 MAUD
4.10 MAUD
3.60 B
About INVION LIMITED
Sector
CEO
Thian Chew
Headquarters
East Kew
Website
Founded
2000
ISIN
AU000000IVX4
FIGI
BBG000PX9K32
Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company was founded on October 11, 2000 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IVX is 0.006 AUD — it has increased by 20.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange INVION LIMITED stocks are traded under the ticker IVX.
IVX stock is 20.00% volatile and has beta coefficient of −0.80. Check out the list of the most volatile stocks — is INVION LIMITED there?
Yes, you can track INVION LIMITED financials in yearly and quarterly reports right on TradingView.
IVX stock has risen by 20.00% compared to the previous week, the month change is a 20.00% rise, over the last year INVION LIMITED has showed a 14.29% decrease.
IVX net income for the last quarter is −714.17 K AUD, while the quarter before that showed −784.12 K AUD of net income which accounts for 8.92% change. Track more INVION LIMITED financial stats to get the full picture.
Today INVION LIMITED has the market capitalization of 32.12 M, it has decreased by 16.67% over the last week.
No, IVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVION LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVION LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVION LIMITED stock shows the sell signal. See more of INVION LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVION LIMITED EBITDA is −811.21 K AUD, and current EBITDA margin is −23.52%. See more stats in INVION LIMITED financial statements.